Creating New Business Areas by Leveraging Technologies for Light, Air and Water
First written in FY2016. 7 of 8 entries say "Advanced", first in FY2017. Latest entry: FY2026.
34 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「From a sustainability perspective, the Company is also pursuing initiatives related to blue carbon and biodiversity. Through industry-academia-government collaboration, it is participating in efforts to conserve and restore seaweed beds in the Seto Inland Sea, using its CFD technology to analyze ocean currents and other factors affecting seaweed-bed growth and considering countermeasures.」
In addition to its existing focus on ZEB, regenerative medicine and IoT, the Company has added the conservation of blue carbon and biodiversity to the scope of its research and development and practical implementation in society. - FY2025AdvancedAnnual report
「The Company is promoting research and development to address customers' increasingly sophisticated and diverse needs and contribute to a sustainable society. It is also pursuing research and development aimed at creating businesses beyond the scope of the comprehensive facilities construction industry, with the goal of achieving sustainable growth.」
The Company continues to develop and specify research and development beyond the conventional scope of facilities construction in multiple areas, including ZEB, regenerative medicine, filter regeneration and the use of AI in facilities operations. - FY2024AdvancedAnnual report
「As one of its CSV business strategies, the Company is working to promote ZEBs to achieve a carbon-neutral society.」
The Company continues research and development and practical implementation in society across business and technology areas beyond the conventional scope of facilities construction, including ZEB, regenerative medicine, filter regeneration and facilities operation. - FY2020AdvancedAnnual report
「The Group is taking on challenges in new areas beyond the conventional boundaries of building facilities, with ZEB, regenerative medicine and IoT as its three pillars. To make regenerative medicine more accessible, it is promoting service businesses through a subsidiary specializing in regenerative medicine and investments in biotechnology ventures, while taking on challenges in new business areas.」
While maintaining the three pillars of its new businesses, the Group has specified service businesses through a subsidiary specializing in regenerative medicine and investments in biotechnology ventures as its means of pursuing them. - FY2019AdvancedAnnual report
「The Group is taking on challenges in new areas beyond the conventional boundaries of building facilities, with ZEB, regenerative medicine and IoT as its three pillars. To make regenerative medicine more accessible, it is promoting technology development through open innovation and actively disseminating information, while taking on challenges in new business areas that leverage the expertise it has developed.」
While maintaining the three pillars of its new business areas, the Group has detailed its promotion of open innovation, technology development and information dissemination in regenerative medicine. - FY2018AdvancedAnnual report
「The Group is taking on challenges in new areas beyond the conventional boundaries of building facilities, with ZEB, regenerative medicine and IoT as its three pillars, and is beginning to achieve results. Going forward, it will continue expanding business areas by leveraging the expertise it has developed and taking on challenges in new business areas.」
The Group identifies ZEB, regenerative medicine and IoT as the three pillars of its new business areas and states that its activities beyond the conventional boundaries of building facilities are beginning to produce results. - FY2017AdvancedAnnual report
「In addition to opening the CPF Open Lab “CERA Lab Tonomachi” in the Life Innovation Center built by Kanagawa Prefecture in Kawasaki, the Company opened a Kobe Office in the Kobe Medical Industry Development Project on Port Island in Kobe. It is promoting the collection of information on regenerative medicine, the building of relationships with universities, research institutions and companies, and innovation with companies from other industries.」
Regarding the creation of business areas leveraging technologies in light, air and water, the Company has opened an open lab and a Kobe Office in the field of regenerative medicine and is working to build relationships and collect information. - FY2016First statedAnnual report
「II. [Business Creation] Creating Business Areas Leveraging Technologies in Light, Air and Water」
This indicates a direction toward creating new business areas based on existing facilities technology.